Publication list
Uploaded publications:
180
2024
2023
Reif, A.,
Bitter, I.,
Buyze, J.,
Cebulla, K.,
Frey, R.,
Fu, D.,
Ito, T.,
Kambarov, Y.,
Llorca, P.,
Oliveira-Maia, A.,
Messer, T.,
Mulhern-Haughey, S.,
Rive, B.,
von Holt, C.,
Young, A.,
Godinov, Y.,
ESCAPE-TRD Investigators:
Esketamine nasal spray versus quetiapine for treatment-resistant depression.
N. Engl. J. Med. 389 (14), 1298-1309, 2023.
2022
Jarecsny, T.,
Trencséni, D.,
Peták, I.,
Mechtler, L.,
Frecska, E.,
Schwab, R.:
A mikrobiom-asszociált gyulladás és a migrén: a bél-agy tengely újabb állomása?.
Gasztroenterol. Hepatol. Szle. 8 (1), 17-22, 2022.
Rihmer, Z.,
Bánki, M.,
Fekete, S.,
Frecska, E.,
Herold, R.,
Janka, Z.,
Kálmán, J.,
Kelemen, O.,
Perczel-Forintos, D.,
Tényi, T.:
A szocializáció szerepe a pszichoszexuális fejlődésben.
Psychiatr Hung. 37 (4), 351-363, 2022.
Journal metrics:
Q4 Medicine (miscellaneous)
Q4 Psychiatry and Mental Health
Szilágyi, A.,
Takács, B.,
Szekeres, R.,
Tarjányi, V.,
Bombicz, M.,
Priksz, D.,
Kovács, A.,
Juhász, B.,
Frecska, E.,
Szilvássy, Z.,
Varga, B.:
Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye.
Biomedicines. 10 (5), 1-19, 2022.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
2021
Szabó, Í.,
Varga, V.,
Dvorácskó, S.,
Farkas, A.,
Körmöczi, T.,
Berkecz, R.,
Kecskés, S.,
Menyhárt, Á.,
Frank, R.,
Hantosi, D.,
Cozzi, N.,
Frecska, E.,
Tömböly, C.,
Krizbai, I.,
Bari, F.,
Farkas, E.:
N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain.
Neuropharmacology. 192 1-13, 2021.
Journal metrics:
Q2 Cellular and Molecular Neuroscience
Q1 Pharmacology
Alaya, A.,
Máthé, A.,
Frecska, E.,
Máthé, E.:
The olive (Olea europaea) and the almond (Prunus amygdalus) related phytonutrients, and the associated health-promoting biological effects, a review.
Agrártud. közl. 2021 (1), 11-24, 2021.
2020
Balázs, J.,
Bitter, I.,
Fekete, S.,
Fodor, L.,
Frecska, E.,
Harmatta, J.,
Janka, Z.,
Kálmán, J.,
Kurimay, T.,
Molnár, K.:
A Magyar Pszichiátriai Társaság és a Pszichiátriai Szakmai Kollégium Pszichiátriai Tagozata és Tanácsa szakmai állásfoglalása Bányai Borbála és Légmán Anna "Életutak a társadalomban pszichiátriai beteg diagnózissal" című közleményével kapcsolatban.
Lege Artis Med. 30 (3), 151-153, 2020.
Nardai, S.,
László, M.,
Szabó, A.,
Alpár, A.,
Hanics, J.,
Zahola, P.,
Merkely, B.,
Frecska, E.,
Nagy, Z.:
N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats.
Exp. Neurol. 327 1-7, 2020.
Journal metrics:
Q1 Developmental Neuroscience
Q1 Neurology
Majer, R.,
Adeyi, O.,
Bagoly, Z.,
Simon, V.,
Csiba, L.,
Kardos, L.,
Hortobágyi, T.,
Frecska, E.:
Neuropsychiatric symptoms, quality of life and caregivers' burden in dementia.
Open Med. 15 (1), 905-914, 2020.
Journal metrics:
Q3 Medicine (miscellaneous)
Szőke-Kovács, Z.,
Móré, E.,
Szőke-Kovács, R.,
Máthé, E.,
Frecska, E.:
Selective inhibition of the serotonin transporter in the treatment of depression: sertraline, fluoxetine and citalopram.
Neuropsychopharmacol. Hung. 22 (1), 4-15, 2020.
Journal metrics:
Q4 Neurology (clinical)
Q4 Neuropsychology and Physiological Psychology
Q4 Neuroscience (miscellaneous)
Q3 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Szőke-Kovács, Z.,
Móré, E.,
Szőke-Kovács, R.,
Máthé, E.,
Frecska, E.:
Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.
Neuropsychopharmacol Hung. 22 (1), 1-14, 2020.
Journal metrics:
Q4 Neurology (clinical)
Q4 Neuropsychology and Physiological Psychology
Q4 Neuroscience (miscellaneous)
Q3 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
2019
Majer, R.,
Simon, V.,
Csiba, L.,
Kardos, L.,
Frecska, E.,
Hortobágyi, T.:
Behavioural and Psychological Symptoms in Neurocognitive Disorders: specific Patterns in Dementia Subtypes.
Open Med. (Wars). 14 (1), 307-316, 2019.
Journal metrics:
Q3 Medicine (miscellaneous)
Nemes, B.,
Pető, K.,
Németh, N.,
Mester, A.,
Magyar, Z.,
Ghanem, S.,
Somogyi, V.,
Tánczos, B.,
Deák, Á.,
Kállay, M.,
Bidiga, L.,
Frecska, E.:
N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model.
Transplant. Proc. 51 (4), 1268-1275, 2019.
Journal metrics:
Q3 Surgery
Q3 Transplantation
Frecska, E.,
Luna, L.:
Subneural foundation of spiritual claims.
In: Unified Theories / Amoroso, R. L., Dienes I., Varga C, Noetic Press, Orinda, CA, 169-182, 2019. ISBN: 0967868777
2024
2023
Reif, A.,
Bitter, I.,
Buyze, J.,
Cebulla, K.,
Frey, R.,
Fu, D.,
Ito, T.,
Kambarov, Y.,
Llorca, P.,
Oliveira-Maia, A.,
Messer, T.,
Mulhern-Haughey, S.,
Rive, B.,
von Holt, C.,
Young, A.,
Godinov, Y.,
ESCAPE-TRD Investigators:
Esketamine nasal spray versus quetiapine for treatment-resistant depression.
N. Engl. J. Med. 389 (14), 1298-1309, 2023.
2022
Jarecsny, T.,
Trencséni, D.,
Peták, I.,
Mechtler, L.,
Frecska, E.,
Schwab, R.:
A mikrobiom-asszociált gyulladás és a migrén: a bél-agy tengely újabb állomása?.
Gasztroenterol. Hepatol. Szle. 8 (1), 17-22, 2022.
Rihmer, Z.,
Bánki, M.,
Fekete, S.,
Frecska, E.,
Herold, R.,
Janka, Z.,
Kálmán, J.,
Kelemen, O.,
Perczel-Forintos, D.,
Tényi, T.:
A szocializáció szerepe a pszichoszexuális fejlődésben.
Psychiatr Hung. 37 (4), 351-363, 2022.
Journal metrics:
Q4 Medicine (miscellaneous)
Q4 Psychiatry and Mental Health
Szilágyi, A.,
Takács, B.,
Szekeres, R.,
Tarjányi, V.,
Bombicz, M.,
Priksz, D.,
Kovács, A.,
Juhász, B.,
Frecska, E.,
Szilvássy, Z.,
Varga, B.:
Therapeutic Properties of Ayahuasca Components in Ischemia/Reperfusion Injury of the Eye.
Biomedicines. 10 (5), 1-19, 2022.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
2021
Szabó, Í.,
Varga, V.,
Dvorácskó, S.,
Farkas, A.,
Körmöczi, T.,
Berkecz, R.,
Kecskés, S.,
Menyhárt, Á.,
Frank, R.,
Hantosi, D.,
Cozzi, N.,
Frecska, E.,
Tömböly, C.,
Krizbai, I.,
Bari, F.,
Farkas, E.:
N,N-Dimethyltryptamine attenuates spreading depolarization and restrains neurodegeneration by sigma-1 receptor activation in the ischemic rat brain.
Neuropharmacology. 192 1-13, 2021.
Journal metrics:
Q2 Cellular and Molecular Neuroscience
Q1 Pharmacology
Alaya, A.,
Máthé, A.,
Frecska, E.,
Máthé, E.:
The olive (Olea europaea) and the almond (Prunus amygdalus) related phytonutrients, and the associated health-promoting biological effects, a review.
Agrártud. közl. 2021 (1), 11-24, 2021.
2020
Balázs, J.,
Bitter, I.,
Fekete, S.,
Fodor, L.,
Frecska, E.,
Harmatta, J.,
Janka, Z.,
Kálmán, J.,
Kurimay, T.,
Molnár, K.:
A Magyar Pszichiátriai Társaság és a Pszichiátriai Szakmai Kollégium Pszichiátriai Tagozata és Tanácsa szakmai állásfoglalása Bányai Borbála és Légmán Anna "Életutak a társadalomban pszichiátriai beteg diagnózissal" című közleményével kapcsolatban.
Lege Artis Med. 30 (3), 151-153, 2020.
Nardai, S.,
László, M.,
Szabó, A.,
Alpár, A.,
Hanics, J.,
Zahola, P.,
Merkely, B.,
Frecska, E.,
Nagy, Z.:
N,N-dimethyltryptamine reduces infarct size and improves functional recovery following transient focal brain ischemia in rats.
Exp. Neurol. 327 1-7, 2020.
Journal metrics:
Q1 Developmental Neuroscience
Q1 Neurology
Majer, R.,
Adeyi, O.,
Bagoly, Z.,
Simon, V.,
Csiba, L.,
Kardos, L.,
Hortobágyi, T.,
Frecska, E.:
Neuropsychiatric symptoms, quality of life and caregivers' burden in dementia.
Open Med. 15 (1), 905-914, 2020.
Journal metrics:
Q3 Medicine (miscellaneous)
Szőke-Kovács, Z.,
Móré, E.,
Szőke-Kovács, R.,
Máthé, E.,
Frecska, E.:
Selective inhibition of the serotonin transporter in the treatment of depression: sertraline, fluoxetine and citalopram.
Neuropsychopharmacol. Hung. 22 (1), 4-15, 2020.
Journal metrics:
Q4 Neurology (clinical)
Q4 Neuropsychology and Physiological Psychology
Q4 Neuroscience (miscellaneous)
Q3 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Szőke-Kovács, Z.,
Móré, E.,
Szőke-Kovács, R.,
Máthé, E.,
Frecska, E.:
Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.
Neuropsychopharmacol Hung. 22 (1), 1-14, 2020.
Journal metrics:
Q4 Neurology (clinical)
Q4 Neuropsychology and Physiological Psychology
Q4 Neuroscience (miscellaneous)
Q3 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
2019
Majer, R.,
Simon, V.,
Csiba, L.,
Kardos, L.,
Frecska, E.,
Hortobágyi, T.:
Behavioural and Psychological Symptoms in Neurocognitive Disorders: specific Patterns in Dementia Subtypes.
Open Med. (Wars). 14 (1), 307-316, 2019.
Journal metrics:
Q3 Medicine (miscellaneous)
Nemes, B.,
Pető, K.,
Németh, N.,
Mester, A.,
Magyar, Z.,
Ghanem, S.,
Somogyi, V.,
Tánczos, B.,
Deák, Á.,
Kállay, M.,
Bidiga, L.,
Frecska, E.:
N,N-dimethyltryptamine Prevents Renal Ischemia-Reperfusion Injury in a Rat Model.
Transplant. Proc. 51 (4), 1268-1275, 2019.
Journal metrics:
Q3 Surgery
Q3 Transplantation
Frecska, E.,
Luna, L.:
Subneural foundation of spiritual claims.
In: Unified Theories / Amoroso, R. L., Dienes I., Varga C, Noetic Press, Orinda, CA, 169-182, 2019. ISBN: 0967868777
Frecska, E.,
Kovács, A.,
Szabó, A.:
The protective role of dimethyltryptamine against ischemia-reperfusion injury.
In: Advances in Psychedelic Medicine: State-of-the-Art Therapeutic Applications. Ed.: M. Winkelman, B. Sessa, Praeger, Santa Barbara, CA, 214-231, 2019. ISBN: 1440864101
2018
Pető, K.,
Németh, N.,
Mester, A.,
Magyar, Z.,
Ghanem, S.,
Somogyi, V.,
Tánczos, B.,
Deák, Á.,
Bidiga, L.,
Frecska, E.,
Nemes, B.:
Hemorheological and metabolic consequences of renal ischemia-reperfusion and their modulation by N,N-dimethyltryptamine on a rat model.
Clin. Hemorheol. Microcirc. 70 (1), 107-117, 2018.
Journal metrics:
Q3 Cardiology and Cardiovascular Medicine
Q3 Hematology
Q3 Physiology
Q3 Physiology (medical)
Penke, B.,
Fülöp, L.,
Szűcs, M.,
Frecska, E.:
The Role of Sigma-1 Receptor, an Intracellular Chaperone in Neurodegenerative Diseases.
Curr. Neuropharmacol. 16 (1), 97-116, 2018.
Journal metrics:
D1 Medicine (miscellaneous)
Q1 Neurology
Q1 Neurology (clinical)
Q1 Pharmacology
Q1 Pharmacology (medical)
Q1 Psychiatry and Mental Health
2017
Majer, R.,
Csiba, L.,
Kardos, L.,
Frecska, E.,
Hortobágyi, T.:
Életminőség, betegségteher és hozzátartozó terhe a neuropszichiátriai tünetek tükrében neurokognitív zavarokban.
Acta Med. Sociol. 8 (24), 23-40, 2017.
Frecska, E.:
Frecska Ede's manifesto.
In: Beyond Fear and Rage : A Manifesto by the Authors of "What is Reality?". Ed.: Laszlo Ervin, Waterfront Press, Lumsden, SK, 23-26, 2017. ISBN: 1945949236
Frecska, E.,
Kovács, A.,
Jeges, B.,
Gajdos, Á.:
Nonlokalitás és sámáni tudatállapot.
In: Közvetítő. Tanulmányok Hoppál Mihály 75. születésnapjára. Szerk.: Czövek Judit, Szulovszky János, Magyar Vallástudományi Társaság, Budapest, 9-31, 2017. ISBN: ISBN9789638769671
Szummer, C.,
Horváth, L.,
Szabó, A.,
Frecska, E.,
Orzói, K.:
The hyperassociative mind: The psychedelic experience and Merleau-Ponty's "wild being".
Journal of Psychedelic Studies. 1 (2), 55-64, 2017.
Kolozsvári, L.,
Kovács, Z.,
Szőllősi, G.,
Kolozsváriné Harsányi, S.,
Frecska, E.,
Égerházi, A.:
Validation of the Hungarian version of the Test Your Memory = a Teszteld a memóriádat (Test Your Memory) magyar változatának validálása.
Ideggyogy. Szle. 70 (7-8), 267-272, 2017.
Journal metrics:
Q4 Neurology
Q4 Neurology (clinical)
2016
Frecska, E.,
Kovács, A.,
Szabó, A.,
Ferencz, C.,
Móré, E.:
Az ayahuasca orvosi alkalmazásának alapjai: a dimetiltriptamin szomatofiziológiája.
Lege Artis Med. 26 (9-10), 413-420, 2016.
Journal metrics:
Q4 Medicine (miscellaneous)
Frecska, E.,
Bokor, P.,
Andrássy, G.,
Kovács, A.:
Az ayahuasca pszichiátriai felhasználásának lehetőségei.
Neuropsychopharmacol. Hung. 18 (2), 79-86, 2016.
Journal metrics:
Q3 Neurology (clinical)
Q4 Neuropsychology and Physiological Psychology
Q4 Neuroscience (miscellaneous)
Q2 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Morvai, S.,
Nagy, A.,
Bálint-Szöllősi, A.,
Móré, E.,
Berecz, R.,
Frecska, E.:
Ketamin alkalmazása súlyos, terápiarezisztens depressziós beteg esetében.
Ideggyógy. Szle. 69 (11-12), 421-425, 2016.
Journal metrics:
Q4 Neurology
Q4 Neurology (clinical)
Szabó, A.,
Kovács, A.,
Riba, J.,
Djurovic, S.,
Rajnavölgyi, É.,
Frecska, E.:
The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells.
Front. Neurosci. 10 1-11, 2016.
Journal metrics:
Q1 Neuroscience (miscellaneous)
Bokor, P.,
Frecska, E.,
Horváth, L.,
Szabó, A.:
Tracking the river of change: a multidimensional interpretation of ayahuasca healing.
In: Tracking the river of change: A multidimensional interpretation of ayahuasca healing. Ed.: Luna, E. L., White, S. F, Synergetic Press, Santa Fe, NM, 232-242, 2016.
Morvai, S.,
Nagy, A.,
Kovács, A.,
Móré, E.,
Berecz, R.,
Frecska, E.:
Unanswered questions in the transcranial magnetic stimulation treatment of patients with depression.
Ideggyogy. Szle. 69 (1-2), 4-11, 2016.
Journal metrics:
Q4 Neurology
Q4 Neurology (clinical)
2015
Szabó, A.,
Kazai, A.,
Frecska, E.,
Brys, Z.:
Pszichedelikumok és kvázi-pszichedelikumok a modern kutatások tükrében: orvosi kannabisz, MDMA, szalvinorin A, ibogain és ayahuasca.
Neuropsychopharmacol. Hung. 17 (3), 120-128, 2015.
Journal metrics:
Q3 Neurology (clinical)
Q3 Neuropsychology and Physiological Psychology
Q4 Neuroscience (miscellaneous)
Q2 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Bokor, P.,
Andrejkovics, M.,
Frecska, E.:
Spiritualitás a medicinában.
In: A Pszichiátria Magyar Kézikönyve / szek. Füredi János, Németh Attila, Medicina Könyvkiadó Zrt., Budapest, 111-116, 2015. ISBN: 9789632265209
Frecska, E.,
Móró, L.,
Wesselman, H.:
The soul cluster: reconsideration of a millennia old concept.
In: The Divine Spark: A Graham Hancock Reader: Psychedelics, Consciousness, and the Birth of Civilization. Ed.: Hancock, Graham, Disinformation Books, San Francisco, CA, 244-270, 2015. ISBN: 1938875117
2014
Asztalos, Z.,
Egervári, L.,
Andrássy, G.,
Faludi, G.,
Frecska, E.:
Katatónia és neuroleptikus malignus szindróma a pszichopatológiai és patofiziológiai átfedések tükrében: rövid összefoglaló tanulmány.
Neuropsychopharmacol. Hung. 16 (1), 19-28, 2014.
Journal metrics:
Q3 Neurology (clinical)
Q4 Neuropsychology and Physiological Psychology
Q3 Neuroscience (miscellaneous)
Q2 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Szabó, A.,
Kovács, A.,
Frecska, E.,
Rajnavölgyi, É.:
Psychedelic N,N-Dimethyltryptamine and 5-Methoxy- N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells.
PLoS One. 9 (8), 2014.
Journal metrics:
D1 Agricultural and Biological Sciences (miscellaneous)
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
D1 Medicine (miscellaneous)
Falussy, L.,
Balla, P.,
Frecska, E.:
Recidíva és inszomnia unipoláris depresszióban.
Neuropsychopharmacol Hung. 16 141-147, 2014.
Journal metrics:
Q3 Neurology (clinical)
Q4 Neuropsychology and Physiological Psychology
Q3 Neuroscience (miscellaneous)
Q2 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Frecska, E.,
Szabó, A.,
Kovács, A.,
Rajnavölgyi, É.:
The Endogenous Hallucinogen N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses Through the sigma-1 Receptor of Human Dendritic Cells.
Neuropsychopharmacology. 39 S620-S621, 2014.
2013
Kövér, L.,
Sándor, J.,
Frecska, E.,
Égerházi, A.:
"Kéz a Kézben"- avagy a párkapcsolati elégedettség vizsgálata.
In: Fókuszban a párterápia : a Magyar Családterápiás Egyesület XXVII. Vándorgyűlése : Programfüzet és absztraktok kivonata, Magyar Családterápiás Egyesület, Budapest, 54, 2013.
Frecska, E.,
Szabó, A.,
Winkelman, M.,
Luna, L.,
McKenna, D.:
A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity.
J. Neural Transm. 120 (9), 1295-1303, 2013.
Journal metrics:
Q2 Biological Psychiatry
Q2 Neurology
Q1 Neurology (clinical)
Q1 Psychiatry and Mental Health
Égerházi, A.,
Balla, P.,
Ritzl, A.,
Varga, Z.,
Frecska, E.,
Berecz, R.:
Automated Neuropsychological Test Battery in depression - preliminary data.
Neuropsychopharmacologia Hung. 15 (1), 5-11, 2013.
Journal metrics:
Q3 Neurology (clinical)
Q3 Neuropsychology and Physiological Psychology
Q4 Neuroscience (miscellaneous)
Q2 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
2012
Frecska, E.,
Kovács, A.,
Balla, P.,
Falussy, L.,
Ferencz, Á.,
Varga, Z.:
The message of the survival curves: I. Composite analysis of long-term treatment studies in bipolar disorder.
Neuropsychopharmacol. Hung. 14 (3), 155-164, 2012.
Journal metrics:
Q4 Neurology (clinical)
Q4 Neuropsychology and Physiological Psychology
Q4 Neuroscience (miscellaneous)
Q3 Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
2011
2010
2009
2008
Strassman, R.,
Wojtowicz, S.,
Luna, L.,
Frecska, E.:
Inner Paths to Outer Space.
Park Street Press, Rochester, VT, 376 p., 2008. ISBN: 9781594772245
2007
Sikter, A.,
Frecska, E.,
Braun, I.,
Gonda, X.,
Rihmer, Z.:
The role of hyperventilation: hypocapnia in the pathomechanism of panic disorder.
Rev. Bras. Psiquiatr. 29 (4), 375-379, 2007.
2006
2005
2004
Arató, M.,
Frecska, E.,
Beck, C.,
An, M.,
Kiss, H.:
Digit length pattern in schizophrenia suggests disturbed prenatal hemispheric lateralization.
Prog. Neuropsychopharmacol. Biol. Psychiatry. 28 (1), 191-194, 2004.
Journal metrics:
Q2 Biological Psychiatry
Q1 Pharmacology
Frecska, E.,
Symer, C.,
White, K.,
Piscani, K.,
Kulcsár, Z.:
Perceptional and executive deficits of chronic schizophrenic patients in attentional and intentional tasks.
Psychiatry Res. 126 (1), 63-75, 2004.
Journal metrics:
Q2 Biological Psychiatry
Q1 Psychiatry and Mental Health
2003
Frecska, E.,
White, K.,
Leonard, C.,
Bengston, M.,
Kuldau, M.:
Binocular rivalry in post-traumatic stress disorder.
Biol. Psychiatry. 53 198S, 2003.
Frecska, E.,
White, K.,
Leonard, C.,
Kuldau, M.,
Bengston, M.,
Ricciuti, N.,
Luna, L.,
Mahoney, B.,
Pettigrew, J.:
Binokuláris rivalizáció szkizofréniában és drog-indukált pszichózisban = Binocular rivalry in schizophrenia and drug-induced psychosis.
Neuropsychopharmacol. Hung. 5 (2), 4-13, 2003.
Rosenheck, R.,
Perlick, D.,
Bingham, S.,
Liu-Mares, W.,
Collins, J.,
Warren, S.,
Leslie, D.,
Allan, E.,
Campbell, C.,
Caroff, S.,
Corwin, J.,
Davis, L.,
Douyon, R.,
Dunn, L.,
Evans, D.,
Frecska, E.,
Grabowski, J.,
Graeber, D.,
Herz, L.,
Kwon, K.,
Lawson, W.,
Mena, F.,
Sheikh, J.,
Smelson, D.,
Smith-Gamble, V.:
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
JAMA. 290 (20), 2693-2702, 2003.
Journal metrics:
D1 Medicine (miscellaneous)
2002
2001
Frecska, E.,
Kulcsár, Z.:
Sotsial'nyye svyazi v modulyatsii fiziologii ritual'nogo transa.
In: Lichnost, kultura, etnos: Sovremennaya psikho-logicheskaya antropologiya. Szerk.: Belik, A. A, Smysl, Moskva, 501-522, 2001. ISBN: 5893570936
1999
Adler, L.,
Rotrosen, J.,
Edson, R.,
Lavori, P.,
Lohr, J.,
Hitzemann, R.,
Raisch, D.,
Caligiuri, M.,
Tracy, K.,
Frecska, E.:
Vitamin E Treatment for Tardive Dyskinesia.
Arch. Gen. Psychiatry. 56 (9), 836-841, 1999.
1998
Davis, K.,
Buchsbaum, M.,
Shihabuddin, L.,
Spiegel-Cohen, J.,
Metzger, M.,
Frecska, E.,
Keefe, R.,
Powchik, P.:
Ventricular enlargement in poor-outcome schizophrenia.
Biol. Psychiatry. 43 (11), 783-793, 1998.
1997
Tracy, K.,
Adler, L.,
Rotrosen, J.,
Edson, R.,
Lavori, P.,
Gowda, S.,
Mukherjee, S.,
Williams, B.,
Duncan, E.,
Schwartz, M.,
Hitzemann, R.,
Frecska, E.,
Manicone, P.,
Caroff, S.,
Campbell, C.,
Havey, J.,
Casey, D.,
Hoffman, W.,
Hansen, T.,
Brundage, T.,
Hixs, M.,
Hanna, M.,
Lohr, J.,
Browning, J.,
Kanof, P.,
Fain, R.,
Krystal, J.,
DSouza, D.,
Damon, D.,
Marder, S.,
Ames, D.,
Ross, D.,
Doorack, J.,
Hitzemann, R.,
Lohr, J.,
Haakenson, C.,
Miller, M.:
Interrater reliability issues in multicenter trials, part I: theoretical concepts and operational procedures used in Department of Veterans Affairs Cooperative Study #3941.
Psychopharmacol. Bull. 33 (1), 53-57, 1997.
Edson, R.,
Lavori, P.,
Tracy, K.,
Adler, L.,
Rotrosen, J.,
Gowda, S.,
Mukherjee, S.,
Williams, B.,
Duncan, E.,
Vaid, G.,
Schwartz, M.,
Hitzemann, R.,
Frecska, E.,
Manicone, P.,
Caroff, S.,
Campbell, E.,
Havey, J.,
Casey, D.,
Hoffman, W.,
Hansen, T.,
Brundage, T.,
Hixs, M.,
Hanna, M.,
Lohr, J.,
Browning, J.,
Kanof, P.,
Fain, R.,
Krystal, J.,
DSouza, D.,
Damon, D.,
Marder, S.,
Ames, D.,
Ross, D.,
Doorack, J.,
Hitzemann, R.,
Haakenson, C.,
Miller, M.:
Interrater reliability issues in multicenter trials, part II: statistical procedures used in Department of Veterans Affairs Cooperative Study #3941.
Psychopharmacol. Bull. 33 (1), 59-67, 1997.
Volkow, N.,
Wang, G.,
Overall, J.,
Hitzemann, R.,
Fowler, J.,
Pappas, N.,
Frecska, E.,
Piscani, K.:
Regional brain metabolic response to lorazepam in alcoholics during early and late alcohol detoxification.
Alcohol. Clin. Exp. Res. 21 (7), 1278-1284, 1997.
Hirschowitz, J.,
Hitzemann, R.,
Piscani, K.,
Burr, G.,
Frecska, E.,
Culliton, D.,
Mann, M.,
Curtis, C.:
The Dose Reduction in Schizophrenia (DORIS) Study: a final report.
Schizophr. Res. 23 (1), 31-43, 1997.
1996
Keefe, R.,
Frecska, E.,
Apter, S.,
Davidson, M.,
Macaluso, J.,
Hirschowitz, J.,
Davis, K.:
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings.
Am. J. Psychiat. 153 (6), 806-811, 1996.
1995
Davidson, M.,
Harvey, P.,
Powchik, P.,
Parrella, M.,
White, L.,
Knobler, H.,
Losonczy, M.,
Keefe, R.,
Katz, S.,
Frecska, E.:
Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.
Am. J. Psychiat. 152 (2), 197-207, 1995.
1994
Frecska, E.,
Losonczy, M.,
Keefe, R.,
Apter, S.,
Davidson, M.,
Mohs, R.,
Davis, K.:
Age-dependent change of ventricular measures in schizophrenia: cross-sectional analysis.
Biol. Psychiatry. 35 704-705, 1994.
1993
White, L.,
Parrella, M.,
Harvey, P.,
Knobler, H.,
Frecska, E.,
Davidson, M.:
Differential diagnosis and cognitive impairment in elderly psychiatric inpatients.
Schizophr. Res. 9 113, 1993.
Macaluso, J.,
Losonczy, M.,
Davidson, M.,
Mohs, R.,
Frecska, E.,
Apter, S.,
Guo, L.,
Schmeidler, J.,
Davis, K.:
Neuroleptic non-responsiveness in schizophrenics with enlarged ventricles.
Biol. Psychiatry. 33 122A, 1993.
Frecska, E.,
Losonczy, M.,
Keefe, R.,
Silverman, J.,
Davidson, M.,
Davis, K.:
The characteristics of poor outcome, 'Kraepelinian' schizophrenia.
Eur. Neuropsychopharmacol. 3 400, 1993.
1992
Frecska, E.,
Losonczy, M.,
Keefe, R.,
Silverman, J.,
Davidson, M.,
Davis, K.:
Characteristics of poor outcome schizophrenia.
Clin. Neuropharmacol. 15 (Suppl_1), 88B, 1992.
Davidson, M.,
Powchik, P.,
Haroutunian, H.,
Purohit, D.,
Perl, D.,
Harvey, P.,
Losonczy, M.,
McCrystal, J.,
Parrella, M.,
White, L.,
Bierer, L.,
Frecska, E.,
Mohs, R.,
Davis, K.:
Dementia in elderly schizophrenic patients.
Biol. Psychiatry. 31 (5), 193A, 1992.
Davidson, M.,
Powchik, P.,
Haroutunian, V.,
Harvey, P.,
Losonczy, M.,
Frecska, E.,
McCrystal, J.,
Bierer, L.,
Parrella, M.,
Katz, S.,
Mohs, R.,
Davis, K.:
Dementia in elderly schizophrenics.
Schizophr. Res. 6 (2), 161-162, 1992.
Davidson, M.,
Powchik, P.,
Haroutunian, V.,
Harvey, P.,
Perl, D.,
Losonczy, M.,
Frecska, E.,
Bierer, L.,
Mohs, R.,
Davis, K.:
Dementia-like symptoms in elderly schizophrenic patients.
Clin. Neuropharmacol. 15 (Suppl_1), 254B, 1992.
White, L.,
Parrella, M.,
Bowler, S.,
Blum, C.,
Frecska, E.,
Fricke, S.,
Ohsiek, R.,
McCrystal, J.,
Young, N.:
Effect of dementia on psychiatric symptoms in geriatric psychiatric inpatients.
Biol. Psychiatry. 31 (5), 152A-153A, 1992.
Perényi, A.,
Goswani, U.,
Frecska, E.,
Arató, M.,
Béla, Á.:
L-Deprenyl in treating negative symptoms of schizophrenia.
Psychiatry Res. 42 (2), 189-191, 1992.
1991
Losonczy, M.,
Frecska, E.,
Davidson, M.,
Keefe, R.,
Davis, K.:
Asymmetrical enlargement of frontal horns in poor prognosis "Kraepelinian" schizophrenics.
Biol. Psychiatry. 29 (9), 92A, 1991.
Frecska, E.,
Losonczy, M.,
Keefe, R.,
McQueeney, R.,
Lobel, D.,
Apter, S.,
Davis, K.:
Characteristics of Kraepelinian schizophrenia: independent replication study.
Biol. Psychiatry. 29 (9), 107A-108A, 1991.
Davidson, M.,
Powchik, P.,
Losonczy, M.,
Katz, S.,
McCrystal, J.,
Parrella, M.,
Frecska, E.,
Haroutunian, V.,
Bierer, L.,
Perl, D.,
Goldstein, M.,
Davis, K.:
Dementia in elderly schizophrenic patients: clinical and neuropathological correlates.
Biol. Psychiatry. 29 91A, 1991.
Frecska, E.,
Losonczy, M.,
Keefe, R.,
Silverman, J.,
Davidson, M.,
Harvey, P.,
McQueeney, R.,
Lobel, D.,
Apter, S.,
Davis, K.:
Kraepelinian schizophrenia: a replication in an independent sample.
Schizophr. Res. 4 (3), 257, 1991.
White, L.,
Parrella, M.,
Bowler, S.,
Blum, C.,
Frecska, E.,
Fricke, S.,
Katz, S.,
McCrystal, J.,
O'Brien, V.,
Ohsiek, R.:
Positive and negative syndrome scale (PANSS) in geriatric schizophrenic inpatients.
Biol. Psychiatry. 29 (9), 76A, 1991.
Frecska, E.,
Lukács, H.,
Arató, M.,
Mód, L.,
Alföldi, A.,
Powchik, P.:
Postdexamethasone serum cortisol level and coping.
In: Stress and Emotion: Anxiety, Anger, and Curiosity. Eds.: C. D. Spielberger, I. G. Sarason, Z. Kulcsar, G. L. Van Heck, Hemisphere Publishing, Washington, DC, 179-186, 1991, (Stress and EmotionISSN ; 14) ISBN: 1560321873
Arató, M.,
Tekes, K.,
Tóthfalusi, L.,
Magyar, K.,
Palkovits, M.,
Frecska, E.,
Falus, A.,
MacCrimmon, D.:
Reversed hemispheric asymmetry of imipramine binding in suicide victims.
Biol. Psychiatry. 29 (7), 699-702, 1991.
Arató, M.,
Frecska, E.,
MacCrimmon, D.,
Guscott, R.,
Saxena, B.,
Tekes, K.,
Tóthfalusi, L.:
Serotonergic interhemispheric asymmetry: Neurochemical and pharmaco-EEG evidence.
Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 15 (6), 759-764, 1991.
Arató, M.,
Tekes, K.,
Tóthfalusi, L.,
Frecska, E.,
Falus, A.,
Palkovits, M.,
MacCrimmon, D.:
Serotonin dysregulation in suicide.
In: Serotonin-Related Psychiatric Syndromes. Clinical and Thera?peutic Links. Eds.: G. B. Cassano, H. S. Akiskal, Royal Society of Medicine Services, Montreal, QC, 41-46, 1991. ISBN: 1853151483
1990
Bartkó, G.,
Frecska, E.,
Horváth, S.,
Zádor, G.,
Arató, M.:
Predicting neuroleptic response from a combination of multilevel variables in acute schizophrenic patients.
Acta Psychiatr. Scand. 82 (6), 408-412, 1990.
Maylath, E.,
Bartkó, G.,
Frecska, E.,
Horváth, S.,
Arató, M.:
Significance of positive and negative symptoms in chronic schizophrenic patients.
Schizophr. Res. 3 71, 1990.
1989
Bartkó, G.,
Zádor, G.,
Frecska, E.,
Horváth, S.,
Arató, M.:
A neuroleptikus kezelés prediktív tényezőinek vizsgálata akut schizophren kórképekben.
Ideggyogy. Szle. 42 245-253, 1989.
Perényi, A.,
Goswani, U.,
Frecska, E.,
Majláth, E.,
Barcs, G.,
Kassay-Farkas, Á.:
A Pilot Study of the Role of Prophylactic Antiparkinson Treatment During Neuroleptic Therapy.
Pharmacopsychiatry. 22 (03), 108-110, 1989.
Perényi, A.,
Goswani, U.,
Arató, M.,
Frecska, E.,
Knoll, J.,
Bela, A.:
Composition for the treatment of schizophrenia.
[szabadalom]
Frecska, E.,
Bagdy, G.,
Perényi, A.,
Arató, M.,
Degrell, I.,
Mogyorosy, Z.:
Multivariate analysis of monoamine indices in patients with chronic schizophrenia.
J. Neuropsychiatr. Clin. Neurosci. 1 (3), 291-295, 1989.
Bartkó, G.,
Frecska, E.,
Zádor, G.,
Herczeg, I.:
Neurological features, cognitive impairment and neuroleptic response in schizophrenic patients.
Schizophr. Res. 2 (3), 311-313, 1989.
Frecska, E.,
Arató, M.,
Bánki, M.,
Mohari, K.,
Perényi, A.,
Bagdy, G.,
Fekete, I.:
Prolactin response to fentanyl in depression.
Biol. Psychiatry. 25 (6), 692-696, 1989.
1988
Perényi, A.,
Frecska, E.,
Majláth, E.,
Kassay-Farkas, Á.,
Barcs, G.,
Bagdy, G.:
Adatok az antiparkinsonos profilaxis mellett.
Ideggyogy. Szle. 41 68-72, 1988.
Perényi, A.,
Goswani, U.,
Béla, Á.,
Frecska, E.,
Arató, M.,
Hegedűs, I.:
Addition of reserpine to ongoing neuroleptic exposure in chronic schizophrenia.
Schizophr. Res. 1 307-308, 1988.
Frecska, E.,
Lukács, H.,
Arató, M.,
Mód, L.,
Alföldi, A.,
Magyar, I.:
Dexamethasone suppression test and coping behavior in psychosocial stress.
Psychiatry Res. 23 (2), 137-145, 1988.
Frecska, E.,
Arató, M.,
Bánki, M.,
Bagdy, G.,
Perényi, A.,
Mohari, K.,
Fekete, I.:
Diurnal variation in fentanyl-induced hormone responses and side effects.
Neuropsychopharmacology. 1 (3), 235-238, 1988.
Bagdy, G.,
Perenyi, G.,
Frecska, E.,
Seregi, A.,
Fekete, I.,
Tóthfalusi, L.,
Magyar, K.,
Bela, A.,
Arató, M.:
Effect of adjuvant reserpine treatment on catecholamine metabolism in schizophrenic patients under long-term neuroleptic treatment.
J. Neural Transm. 71 (1), 73-78, 1988.
Frecska, E.,
Perényi, A.,
Bagdy, G.,
Arató, M.,
Béla, Á.,
Degrell, I.,
Fekete, I.:
Multivariate-analysis of CSF monoamines, their metabolites, serum prolactin and dopamine-beta-hydroxylase in schizophrenics.
Schizophr. Res. 1 (2-3), 140, 1988.
Bartkó, G.,
Zádor, G.,
Horváth, S.,
Arató, M.,
Frecska, E.:
Pozitív és negatív tünetek krónikus schizophren betegeknél.
Ideggyogy. Szle. 41 353-361, 1988.
1987
1986
Bagdy, G.,
Rihmer, Z.,
Frecska, E.,
Szádóczky, E.,
Arató, M.:
Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Psychoneuroendocrinology. 11 (1), 117-120, 1986.
Faludi, G.,
Kaskó, M.,
Perényi, A.,
Arató, M.,
Frecska, E.:
The dexamethasone suppression test in panic disorder and major depressive episodes.
Biol. Psychiatry. 21 (11), 1008-1014, 1986.
1985
Perényi, A.,
Frecska, E.,
Bagdy, G.,
Révai, K.:
Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment.
Acta Psychiatr. Scand. 72 (5), 430-435, 1985.
Bagdy, G.,
Perényi, A.,
Frecska, E.,
Révai, K.,
Papp, Z.,
Fekete, I.,
Arató, M.:
Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
Psychopharmacology. 85 (1), 62-64, 1985.
Perényi, A.,
Arató, M.,
Bagdy, G.,
Frecska, E.,
Szűcs, R.:
Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
J. Clin. Psychiatry. 46 (6), 229-231, 1985.
1984
Show all
updated: 2024-11-10, 01:33